Physician profile
Peter Licht
NPI 1841267457
$15,372.88
in general payments reported to CMS, 2019-2025
52 companies · $1,706 in 2025
The $1,706 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,639 · 2020: $2,078 · 2021: $2,461 · 2022: $2,268 · 2023: $2,311 · 2024: $2,909 · 2025: $1,706.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,926.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,243.14 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $2,187.87 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $1,569.03 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $732.03 | 2021-2025 | |
| Novo Nordisk INC | $700.01 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $643.60 | 2019-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $533.85 | 2019-2024 | Jardiance |
| Esperion Therapeutics, INC. | $526.04 | 2021-2024 | Nexletol |
| Janssen Pharmaceuticals, INC | $484.45 | 2019-2022 | |
| Pfizer INC. | $467.98 | 2019-2025 | |
| Lundbeck LLC | $437.70 | 2020-2025 | Rexulti, Brintellix |
| Exact Sciences Corporation | $412.14 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $380.86 | 2019-2022 | |
| Lilly USA, LLC | $306.70 | 2019-2025 | Jardiance, Emgality, Zepbound |
| Mylan Specialty L.P. | $301.95 | 2019-2024 | Yupelri |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Licht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.